CohBar Inc
Change company Symbol lookup
Select an option...
CWBR CohBar Inc
TSLA Tesla Inc
WEC WEC Energy Group Inc
PFE Pfizer Inc
T AT&T Inc
BFC Bank First Corp
RIGMF Ridgestone Mining Inc
BAC Bank of America Corp
WFC Wells Fargo & Co
ASB Associated Banc-Corp
Go

Health Care : Biotechnology | Small Cap Blend
Company profile

CohBar, Inc. (CohBar), is a clinical stage biotechnology company. The Company is focused on the research and development of mitochondria-based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The Company has discovered more than 100 mitochondrial-derived peptides and is focused on the development of these peptides into therapeutics that offer the potential to address a broad range of diseases, including nonalcoholic steatohepatitis (NASH), obesity, cancer, fibrotic diseases including idiopathic pulmonary fibrosis (IPF), type 2 diabetes (T2D), cardiovascular and neurodegenerative diseases. The Company’s lead compound, CB4211, is in the phase 1b stage of a phase 1a/1b clinical trial for NASH and obesity. In addition, CohBar has four preclinical programs that include MBT5 Analogs (CXCR4 Antagonists) for Cancer and Other Disease Indicatio, MBT2 Analogs for Fibrotic Diseases, MBT3 Analog for Cancer Immunotherapy and CB5064 Analogs for Type 2 Diabetes.

Closing Price
$1.50
Day's Change
-0.03 (-1.96%)
Bid
--
Ask
--
B/A Size
--
Day's High
1.60
Day's Low
1.46
Volume
(Light)
Volume:
316,976

10-day average volume:
714,024
316,976

Ideanomics' stock soars on heavy volume after order for 200 EVs in China

1:49 pm ET June 22, 2020 (MarketWatch)
Print

Shares of Ideanomics Inc. (IDEX) soared 53% toward a 19-month high in very active afternoon trading Monday, after the facilitator of the adoption of electric vehicles (EVs) announced an order for 200 EVs in China. Trading volume was 291.2 million shares, compared with the full-day average of about 23.8 million shares, and enough to make the stock the most actively traded on major U.S. exchanges. The company said its Mobile Energy Global (MEG) subsidiary secured the order, which was valued at RMB24 million ($3.2 million), or about $16,000 per vehicle. The company said the order will be filled with Dongfeng Liuzhou S50EV models, with delivery of the vehicles to Neijiang City expected to be completed in mid-July. The stock, which is on track to close at the highest level since November 2018, has rocketed 6-fold (up 506%) over the past three months, while shares of EV rivals Tesla Inc. (TSLA) have rallied 134% and Nio Inc. (NIO) have climbed 216% over the same time, and the S&P 500 has gained 35%.

-Tomi Kilgore; 415-439-6400; AskNewswires@dowjones.com

(END) Dow Jones Newswires

June 22, 2020 13:49 ET (17:49 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.